Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/20508
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ekinci, Elif I | - |
dc.contributor.author | Barr, Elizabeth L M | - |
dc.contributor.author | Barzi, Federica | - |
dc.contributor.author | Hughes, Jaquelyne T | - |
dc.contributor.author | Lawton, Paul D | - |
dc.contributor.author | Jones, Graham R D | - |
dc.contributor.author | Hoy, Wendy | - |
dc.contributor.author | Cass, Alan | - |
dc.contributor.author | Thomas, Mark | - |
dc.contributor.author | Sinha, Ashim | - |
dc.contributor.author | Jerums, George | - |
dc.contributor.author | O'Dea, Kerin | - |
dc.contributor.author | MacIsaac, Richard J | - |
dc.contributor.author | Maple-Brown, Louise J | - |
dc.date | 2019-02-21 | - |
dc.date.accessioned | 2019-04-02T01:07:33Z | - |
dc.date.available | 2019-04-02T01:07:33Z | - |
dc.date.issued | 2019-05 | - |
dc.identifier.citation | Journal of Diabetes and Its Complications 2019; 33(5): 343-349 | en_US |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/20508 | - |
dc.description.abstract | Glomerular hyperfiltration is not able to be detected in clinical practice. We assessed whether hyperfiltration is associated with albuminuria progression among Indigenous Australians at high risk of diabetes and kidney disease to determine its role in kidney disease progression. Longitudinal observational study of Indigenous Australians aged ≥18 years recruited from >20 sites, across diabetes and/or kidney function strata. At baseline, iohexol clearance was used to measure glomerular filtration rate (mGFR) and hyperfiltration was defined as (i) a mGFR of ≥125 mL/min/1.73 m2, and (ii) an age-adjusted definition, with the top 10% of the mGFR for each 10 year age group at baseline. Baseline and follow-up urine albumin-to-creatinine ratio (uACR) was collected, and linear regression was used to assess the associations of hyperfiltration and uACR at follow up. 407 individuals (33% men, mean age 47 years) were followed-up for a median of 3 years. At baseline, 234 had normoalbuminuria and 173 had albuminuria. Among participants with normoalbuminuria, those with mGFR ≥125 mL/min/1.73 m2 had 32% higher uACR at follow-up (p = 0.08), and those with age-adjusted hyperfiltration had 60% higher uACR (p = 0.037) compared to those who had normofiltration. These associations were independent of uACR at baseline, but attenuated by HbA1c. Associations were stronger among those without than those with albuminuria at baseline. Although not available for assessment in current clinical practice, hyperfiltration may represent a marker of subsequent albuminuria progression among individuals who have not yet developed albuminuria. | en_US |
dc.language.iso | eng | - |
dc.subject | Albuminuria | en_US |
dc.subject | Chronic kidney disease | en_US |
dc.subject | Diabetic kidney disease | en_US |
dc.subject | Diabetic nephropathy | en_US |
dc.subject | Hyperfiltration | en_US |
dc.subject | Indigenous Australians | en_US |
dc.title | Is hyperfiltration associated with higher urine albumin-to-creatinine ratio at follow up among Indigenous Australians? The eGFR follow-up study. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Journal of Diabetes and Its Complications | en_US |
dc.identifier.affiliation | University of New South Wales Sydney, Sydney, Australia | en_US |
dc.identifier.affiliation | School of Population Health, University of South Australia, Australia | en_US |
dc.identifier.affiliation | Department of Endocrinology and Diabetes, St Vincent's Hospital Melbourne and the University of Melbourne, Melbourne, Australia | en_US |
dc.identifier.affiliation | Diabetes and Endocrinology, Cairns Base Hospital, Cairns, Australia | en_US |
dc.identifier.affiliation | Royal Perth Hospital, Perth, Australia | en_US |
dc.identifier.affiliation | Menzies School of Health Research, Charles Darwin University, Australia | en_US |
dc.identifier.affiliation | The University of Queensland Centre for Chronic Disease, Queensland, Australia | en_US |
dc.identifier.affiliation | Medicine (University of Melbourne) | en_US |
dc.identifier.affiliation | Endocrinology | en_US |
dc.identifier.affiliation | Baker Heart and Diabetes Institute, Melbourne, Australia | en_US |
dc.identifier.affiliation | Division of Medicine, Royal Darwin Hospital, Darwin, Australia | en_US |
dc.identifier.affiliation | SydPath, St Vincent's Hospital, Sydney, Australia | en_US |
dc.identifier.doi | 10.1016/j.jdiacomp.2019.02.005 | en_US |
dc.type.content | Text | en_US |
dc.identifier.orcid | 0000-0003-2372-395X | en_US |
dc.identifier.pubmedid | 30904420 | - |
dc.type.austin | Journal Article | - |
local.name.researcher | Ekinci, Elif I | |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Endocrinology | - |
crisitem.author.dept | Endocrinology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.